NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open1,501.9
High1,541
Low1,499.8
Prev. Close1,505.2
Avg. Traded Price1,528.64
Volume10,25,589
MARKET DEPTH
Total bid1,70,119.00
Total ask1,53,868.00
| Orders | Qty | Bid |
|---|
| 1 | 16 | 1534.6 |
| 2 | 66 | 1534.5 |
| 4 | 90 | 1534.4 |
| 2 | 79 | 1534.3 |
| 4 | 296 | 1534.2 |
| Ask | Qty | Orders |
|---|
| 1534.9 | 1 | 67 |
| 1535 | 5 | 201 |
| 1535.1 | 2 | 162 |
| 1535.2 | 4 | 396 |
| 1535.3 | 5 | 486 |
HIGH/LOW
LOW/HIGH
₹1,499.80an hour ago
₹1,541.0016 minutes ago
Franklin India Opportunities Fund(G)
3Y Return+34.9%
NAV₹246.48
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
SBI Healthcare Opp Fund-Reg(IDCW)
3Y Return+29.1%
NAV₹268.69
SBI Long Term Equity Fund-Reg(IDCW)
Cipla Limited, established in 1935, is a global pharmaceutical company with a strong commitment to make medicines accessible and affordable to those in need. The company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Its product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS and various other key therapeutic segments. With a rich portfolio, the company is deepening its presence in the home markets of India, as well as South Africa, North America and other key regulated and emerging markets.
